1800-272-662
Shopping Cart 0
countryflagAU
Login

Life Science REIT PLC

Real Estate GB LABS

39.2GBX
-0.8(2.00%)

Last update at 2026-03-11T12:51:00Z

Day Range

38.8040.00
LowHigh

52 Week Range

54.4376.32
LowHigh

Fundamentals

  • Previous Close 40.00
  • Market Cap214.20M
  • Volume1274075
  • P/E Ratio-
  • Dividend Yield6.51%
  • Revenue TTM19.30M
  • Revenue Per Share TTM0.06
  • Gross Profit TTM 1.28M
  • Diluted EPS TTM-0.08

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31
Type yearly yearly
Date 2022-12-31 2021-12-31
Income before tax -27.46700M 7.74M
Minority interest - -
Net income -27.61300M 7.74M
Selling general administrative 7.55M 0.38M
Selling and marketing expenses - -
Gross profit -19.92000M 8.12M
Reconciled depreciation - -
Ebit 5.33M -0.72480M
Ebitda -27.46700M 7.74M
Depreciation and amortization - -
Non operating income net other - -
Operating income -27.46700M 7.74M
Other operating expenses 7.55M 0.38M
Interest expense 3.78M 0.00000M
Tax provision 0.15M 0.00000M
Interest income 3.25M 0.00700M
Net interest income -0.52700M 0.00700M
Extraordinary items - -
Non recurring - -
Other items - -
Income tax expense 0.15M -
Total revenue -19.92000M 8.12M
Total operating expenses 7.55M 0.38M
Cost of revenue - -
Total other income expense net - -
Discontinued operations - -
Net income from continuing ops -27.61300M 7.74M
Net income applicable to common shares - 18.58M
Preferred stock and other adjustments - -
Breakdown 2022-12-31 2021-12-31
Type yearly yearly
Date 2022-12-31 2021-12-31
Total assets 447.82M 361.40M
Intangible assets - -
Earning assets - -
Other current assets 4.00M 1.39M
Total liab 128.37M 10.82M
Total stockholder equity 319.45M 350.58M
Deferred long term liab - -
Other current liab -1.02700M 9.31M
Common stock 3.50M 3.50M
Capital stock 3.50M 3.50M
Retained earnings -19.87200M 7.74M
Other liab - -
Good will - -
Other assets 422.55M -
Cash 10.61M 165.96M
Cash and equivalents - -
Total current liabilities 1.03M 10.82M
Current deferred revenue - -
Net debt 99.22M -165.96200M
Short term debt - -
Short long term debt - -
Short long term debt total 109.83M -
Other stockholder equity 335.82M 339.34M
Property plant equipment - 192.17M
Total current assets 20.97M 166.94M
Long term investments 4.30M -
Net tangible assets - 350.58M
Short term investments - -
Net receivables 10.37M 0.98M
Long term debt - -
Inventory - -
Accounts payable 1.03M -
Total permanent equity - -
Noncontrolling interest in consolidated entity - -
Temporary equity redeemable noncontrolling interests - -
Accumulated other comprehensive income - -
Additional paid in capital - -
Common stock total equity - -
Preferred stock total equity - -
Retained earnings total equity - -
Treasury stock - -
Accumulated amortization - -
Non currrent assets other -4.30300M -
Deferred long term asset charges - -
Non current assets total 4.30M -
Capital lease obligations - -
Long term debt total - -
Breakdown 2022-12-31 2021-12-31
Type yearly yearly
Date 2022-12-31 2021-12-31
Investments -186.37800M -181.51700M
Change to liabilities 0.00000M 0.00000M
Total cashflows from investing activities - -435.64080M
Net borrowings - -
Total cash from financing activities 67.11M 343.94M
Change to operating activities - 17.02M
Net income -26.94000M 7.73M
Change in cash -120.35600M 165.96M
Begin period cash flow 165.96M 0.00000M
End period cash flow 45.61M 165.96M
Total cash from operating activities -1.08800M 3.54M
Issuance of capital stock 0.00000M 350.00M
Depreciation - -
Other cashflows from investing activities - 0.02M
Dividends paid 3.50M 0.00000M
Change to inventory - -
Change to account receivables - -7.60560M
Sale purchase of stock - -
Other cashflows from financing activities 96.87M -6.05900M
Change to netincome - -19.50000M
Capital expenditures 7.64M 7.64M
Change receivables - -
Cash flows other operating - -
Exchange rate changes - -
Cash and cash equivalents changes - -
Change in working capital -5.46000M 3.92M
Stock based compensation - -
Other non cash items 31.31M -8.11800M
Free cash flow -1.08800M 3.54M

Peer Comparison

Sector: Real Estate Industry: REIT - Healthcare Facilities

Company Change (GBX) Price (GBX) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
LABS
Life Science REIT PLC		 -0.8 2.00% 39.20 - - 37.01 0.69
PHP
Primary Health Properties		 -0.9551 0.93% 101.24 - 14.84 8.81 0.92 70.21
THRL
Target Healthcare REIT Ltd		 -1.245 1.22% 101.16 - 14.35 7.47 0.82 5.13 26.25

Reports Covered

Stock Research & News

View All

Key Executives

Name Title Year Born
Mr. Simon Farnsworth Managing Director NA
Tamara Deering Head of Financial Planning & Reporting NA
Mr. David Lewis Director of Operations & Fin. NA
Ms. Stephanie Adams Legal Counsel NA
Dr. Sally Ann Forsyth O.B.E., Ph.D. Independent Non-Exec. Director & Sustainability Lead NA
Mr. Ian Harris Director of Asset Management NA
Ms. Pippa Stacey Head of ESG & Consultant NA
Daniel Williams Corp. & Devel. Financial Controller NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.